BUILDING PARTNERSHIPS WITH BIOTECH CONSULTANTS
At Catalent we recognize and support the consultant’s role in biotech.
Why Catalent for Biotech Consultants?
The pharmaceutical and biotech industry continues to evolve rapidly. At Catalent we recognize and support the consultant’s role, helping our partners to stay in tune with the latest advancements, technologies and solutions available. Let us help you by being your partner. Catalent is a global leader in providing integrated services, superior delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products. Bring your challenges, whether they be complex or simple we are here to help you with strong scientific advice and experts in the industry.
Catalent. More products. Better treatments. Reliably Supplied.™
We have over 1000 products in development at any time and have extensive partnerships with pharmaceutical and biopharmaceutical companies of all sizes, from small or virtual organizations to large multinationals. We scale our approach according to what our customers need for their program to be a success.
Aligning Clinical Supply Strategy with the Target Product Profile for your Clients
Learn the strategies to avoid costly pitfalls in pharmaceutical consulting and Gain inside tips on using CDMO’s to deliver solutions to your clients.
Strategies to Avoid Dangerous Pitfalls in Pharmaceutical Consulting
Learn the strategies to avoid costly pitfalls in pharmaceutical consulting and Gain inside tips on using CDMO’s to deliver solutions to your clients.
Discover the Latest Funding, Drug Development and Clinical Solutions Strategies
Dramatically shifting the attention of the industry, Covid-19 forced orphan developers to re-examine their go-to-market strategies.
Advance Your Program Through Target Product Profile Definition and Dose Design
In this exclusive webinar designed for drug developers and pharmaceutical and biotechnology consultants, experts review the importance of the Target Product Profile (TPP).
Strategies for Integrated Business, Regulatory, & Scientific Needs of CMC Clients
Drug development requires integrating multi-disciplinary business, regulatory and scientific activities. To successfully support a client’s program, it is imperative to provide advice and services that support all three…
Utilizing Phase-Appropriate CMC Strategies Throughout Clinical Development
Learn how to accelerate and de-risk clinical-stage drug programs by understanding phase-appropriate strategies that can give your molecule the best chance for success!